Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Cancers
|
May 16, 2023
Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer
Gengguo Deng, Jiannan He, Qunxiong Huang, et al.
Optics Letters
|
April 1, 2024
Design and demonstration of high efficiency perfectly vertical grating couplers with a random structure
Xin Jin, Jinbin Xu, Cuiwei Xue, et al.
Psychopharmacology
|
April 7, 2017
The role of beta-arrestin2 in shaping fMRI BOLD responses to dopaminergic stimulation
Kristoffer Sahlholm, Giovanna D Ielacqua, Jinbin Xu, et al.
Nuclear Medicine and Biology
|
September 9, 2018
Preliminary evaluation of a novel <sup>18</sup>F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer
Dong Zhou, Jinbin Xu, Cedric Mpoy, et al.
Journal of Medicinal Chemistry
|
May 14, 2014
Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands
Suping Bai, Shihong Li, Jinbin Xu, et al.
Journal of Medicinal Chemistry
|
February 11, 2009
Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter
Zhude Tu, Simon M N Efange, Jinbin Xu, et al.
Biomedicines
|
June 2, 2021
Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
Dong Zhou, Huaping Chen, Cedric Mpoy, et al.
Bioorganic & Medicinal Chemistry
|
February 8, 2014
Synthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography
Dong Zhou, Wenhua Chu, Jinbin Xu, et al.
Plos One
|
February 24, 2012
No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease
LinLin Tian, Morvarid Karimi, Susan K Loftin, et al.
Journal of Neurochemistry
|
October 16, 2019
The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases
Huifangjie Li, Pengfei Yang, William Knight, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Cancers
|
May 16, 2023
Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer
Gengguo Deng, Jiannan He, Qunxiong Huang, et al.
Optics Letters
|
April 1, 2024
Design and demonstration of high efficiency perfectly vertical grating couplers with a random structure
Xin Jin, Jinbin Xu, Cuiwei Xue, et al.
Psychopharmacology
|
April 7, 2017
The role of beta-arrestin2 in shaping fMRI BOLD responses to dopaminergic stimulation
Kristoffer Sahlholm, Giovanna D Ielacqua, Jinbin Xu, et al.
Nuclear Medicine and Biology
|
September 9, 2018
Preliminary evaluation of a novel <sup>18</sup>F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer
Dong Zhou, Jinbin Xu, Cedric Mpoy, et al.
Journal of Medicinal Chemistry
|
May 14, 2014
Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands
Suping Bai, Shihong Li, Jinbin Xu, et al.
Journal of Medicinal Chemistry
|
February 11, 2009
Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter
Zhude Tu, Simon M N Efange, Jinbin Xu, et al.
Biomedicines
|
June 2, 2021
Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
Dong Zhou, Huaping Chen, Cedric Mpoy, et al.
Bioorganic & Medicinal Chemistry
|
February 8, 2014
Synthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography
Dong Zhou, Wenhua Chu, Jinbin Xu, et al.
Plos One
|
February 24, 2012
No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease
LinLin Tian, Morvarid Karimi, Susan K Loftin, et al.
Journal of Neurochemistry
|
October 16, 2019
The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases
Huifangjie Li, Pengfei Yang, William Knight, et al.
Page
of 10